Surgery in microscopically pathological N2 non-small cell lung cancer: the size of lymph node matters

The optimal therapeutic intervention of pathologic N2 (pN2) non-small cell lung cancer (NSCLC) is still controversial. The argument and the debate about the selection of patients for multimodality therapy, the role of surgery, the choice of neoadjuvant treatment and sequential therapies have continued for years.